Login

Friále invest in start-ups all over the world|Bryan Frist,Managing Partner,Friale 00:10:00

Share On Facebook Share On Twitter

Bryan Frist is the Founder & Managing Partner of Friále.

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
CEO Donal Murphy Addresses DCC - SEI Gathering 2022 | Donal Murphy - CEO of DCC plc
00:10:00
Focus on Significant technology or business model innovation|David Weiden,Founding Partner and Managing Director,Khosla Ventures
00:10:00
Bannerman Energy: Advancing Namibia's Shovel-Ready Uranium Project
00:10:00
Opportunities and Innovations in Financial Technology and Capital Markets.
00:10:00
Kaufman Rawson Unveils New Brand Reflecting Future Focus
00:10:00
Exclusive Interview: Richard Youle, Co-Head of Private Equity at Skadden Arps, Shares Insights | John Slate - Founder of Skadden
00:10:00
Manzanillo III Project Congratulates HEI: 40 Years of Brighter Futures | Cao Zhian - Chairman of Harbin Electric
00:10:00
Marathoon Fund Management | Dr Michael Anderson, Managing Director at Firefinch Limited
00:00:00
Martha Grogan, M.D. Cardiologist, Mayo Clinic / Why early diagnosis and targeted treatment matter
00:10:00
CEO Jacques Sanche von Bucher Industries: Start ins Neue Jahr vielversprechend trotz konjunktureller Unsicherheiten | Jacques Sanche - CEO of Bucher Industries AG
00:10:00
Finding Financial Normalcy with Jessi Chadd | Jessi Chadd, Principal, Aspyre Wealth Partners.
00:10:00
RNC Minerals: Exciting Gold Discovery Sparks Investor Interest

© 2026 Nehu